Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04364256 · ClinicalTrials.gov registry record · NA
Muscle Stimulation for Physical Function During Stem Cell Transplant
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT04364256: Completed NA study, sponsored by VA Office of Research and Development.
NCT04364256 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 46 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04364256, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
Some blood, bone marrow, and lymphatic (hematologic) cancers such as Hodgkin/Non-Hodgkin lymphomas, chronic lymphocytic leukemia, and multiple myeloma, are over-represented in Veterans due to exposures including Agent Orange and an increased percentage of patients of African American ethnicity. Hematologic transplantation (HCT) is a common treatment for these cancers, but often leads to deconditioning, fatigue, muscle atrophy, and poor quality of life, which are associated with complications such as hospitalization and infection. Despite the significance of these symptoms, there are no approved treatments to prevent/reverse these long-term effects. The cancer itself, side effects of chemotherapy, and sedentary behavior, contribute to these effects. Although exercise before and after HCT has helped reduce these effects, it is inconsistently recommended to patients and most remain sedentary through and after treatment. The investigators are testing an alternative exercise strategy, neuromuscular electrical stimulation, to maintain physical function quality of life after HCT.
Interventions
- DEVICE RS-4i Plus Sequential Stimulator (RS Medical, Vancouver, WA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2021-05-14 |
| Est. Completion | 2025-12-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04364256
The ClinicalTrials.gov registry entry for NCT04364256 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RS-4i Plus Sequential Stimulator (RS Medical, Vancouver, WA) is the first listed.
NCT04364256 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04364256 about?
NCT04364256 is a clinical study titled "Muscle Stimulation for Physical Function During Stem Cell Transplant". Some blood, bone marrow, and lymphatic (hematologic) cancers such as Hodgkin/Non-Hodgkin lymphomas, chronic lymphocytic leukemia, and multiple myeloma, are over-represented in Veterans due to exposures including Agent Orange and an increased percentage of patients of African American ethnicity. Hema...
What is the current status of trial NCT04364256?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2021-05-14. Estimated completion is 2025-12-29.
What interventions are being tested in trial NCT04364256?
The interventions under investigation include: RS-4i Plus Sequential Stimulator (RS Medical, Vancouver, WA) (DEVICE).
Who is sponsoring clinical trial NCT04364256?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.